Social Media

What does Twitter's 280 characters mean for pharma?

What does Twitter's 280 characters mean for pharma?

By

Marketers survey the pluses and minuses of the platform's new 280-character limit.

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

By

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Experts say pharma's move to Snapchat is in the making

Experts say pharma's move to Snapchat is in the making

By

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Always ad '#LikeAGirl' returns to fight girls' fear of failure

By

Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.

Facebook ramps up video offer with revamped Watch tab

Facebook ramps up video offer with revamped Watch tab

By

Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

By By

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Allergan ramps up promotion for new rosacea drug

Allergan ramps up promotion for new rosacea drug

By

The drugmaker began advertising for Rhofade on Facebook in early August.

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

By

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Twitter launches DM cards for brands

Twitter launches DM cards for brands

Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.

Five things for pharma marketers to know: Tuesday, May 23, 2017

Five things for pharma marketers to know: Tuesday, May 23, 2017

By

Disease awareness ads can boost drug sales; AstraZeneca's experimental asthma drug cuts steroid use; FDA approves Regeneron and Sanofi's RA drug

Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

By

The drugmaker is is using Tumblr, Snapchat, and YouTube as well as gay dating apps like Grindr to promote its HIV prevention pill.

Excedrin acts fast to ease Mets fan's headache

Excedrin acts fast to ease Mets fan's headache

By

Excedrin jumped at the chance to help relieve an angry fan's headache when he missed opening day of the New York Mets season due to train delays.

Saturday at SXSW: Hooray for health

Saturday at SXSW: Hooray for health

By

The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.

Some CME experts remain skeptical when it comes to social media

Some CME experts remain skeptical when it comes to social media

By

There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.

MM&M's top 5 stories in February 2017

MM&M's top 5 stories in February 2017

By

WPP creates WPP Health & Wellness; Publicis Health formalizes new name; 10 ways healthcare companies are testing Instagram

Why Pharma Refuses to See Value in 'Influence'

Why Pharma Refuses to See Value in 'Influence'

At the very least, pharma marketers need to make sure they know the difference between search engine marketing and search engine optimization.

10 ways healthcare companies are testing Instagram

10 ways healthcare companies are testing Instagram

By

Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.

How can drugmakers tell better stories? Try Instagram

How can drugmakers tell better stories? Try Instagram

By

The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.

Five things for pharma marketers to know: Wednesday, January 11, 2017

Five things for pharma marketers to know: Wednesday, January 11, 2017

By

The FDA accepts Keytruda combo for review; Valeant offloads Dendreon and skincare brands; pharmacies feeling the squeeze from Express Scripts

How different generations form online "tribes"

How different generations form online "tribes"

By

Facebook and Instagram are the primary location for brands to engage with online tribes, while Raptr and PlayFire are a hit with boomers.

CME providers use Facebook Live to educate doctors

CME providers use Facebook Live to educate doctors

By

A recent CME course using Facebook Live generated 34,000 views and 600 comments.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

How Duchesnay USA got over the Kardashian marketing bump

How Duchesnay USA got over the Kardashian marketing bump

By

The drugmaker still views Instagram as a viable marketing platform, however.

10 things for pharma marketers to know about Facebook and Instagram

10 things for pharma marketers to know about Facebook and Instagram

By

With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.

Five things for pharma marketers to know: Tuesday, November 1, 2016

Five things for pharma marketers to know: Tuesday, November 1, 2016

By

Facebook opens up to pharma; Pfizer nixes PCSK9 inhibitor in development; Cardinal Health cuts forecast on dwindling price increases

Warning letters most often stem from missing risk information

Warning letters most often stem from missing risk information

By

The number of warning and untitled letters has dropped in recent years. Only four letters have been sent so far this year, compared to 28 in 2012.

Why Excedrin embraced the headache of a contentious election season

Why Excedrin embraced the headache of a contentious election season

By

Excedrin's #DebateHeadache was inspired by complaints the brand noticed during the first presidential debate in September.

Five things for pharma marketers to know: Wednesday, October 19, 2016

Five things for pharma marketers to know: Wednesday, October 19, 2016

By

Roche gets FDA approval for immunotherapy Tecentriq; insurers are sued for discrimination; the FDA proposes yanking generic ADHD drugs from market

Best Use of Social Media of 2016

Best Use of Social Media of 2016

By

Digitas Health LifeBrands used Snapchat and Twitter to drive immuno­deficiency patient Seth's story. The effort garnered 188 million impressions for #wearyellowforseth.

MM&M's 5 most popular stories in September 2016

MM&M's 5 most popular stories in September 2016

By

Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines